Fractyl Health (GUTS) Equity Average (2023 - 2026)

Fractyl Health (GUTS) has 4 years of Equity Average data on file, last reported at $15.4 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 11.39% year-over-year to $15.4 million; the trailing twelve-month figure through Mar 2026 stood at $15.4 million (down 11.39% YoY), and the FY2025 full-year result was $18.9 million, up 112.77% from the prior year.
• Equity Average for Q1 2026 stood at $15.4 million, up from $3.1 million in the prior quarter.
• Across five years, Equity Average topped out at $77.5 million in Q2 2024 and bottomed at -$316.1 million in Q4 2023.
• A 4-year average of -$68.1 million and a median of -$1.4 million in 2025 frame the typical range for Equity Average.
• Across the five-year window, Equity Average surged 127.87% in 2024 and plunged 117.67% in 2025, its largest moves.
• Tracing GUTS's Equity Average over 4 years: stood at -$316.1 million in 2023, then soared by 112.46% to $39.4 million in 2024, then slumped by 92.02% to $3.1 million in 2025, then surged by 391.0% to $15.4 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $15.4 million, $3.1 million, and -$10.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison